Feng Zhang, Han Altae-Tran, Soumya Kannan
The patent application provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides novel class 1, Type IV and novel class I, Type I Cas proteins and their use in modifying target sequences.